Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lithium dosage in the elderly. A study with matched age groups.

W Greil, M C Stoltzenburg, M L Mairhofer

    Journal of Affective Disorders
    |July 1, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A Rare Case of Emberger Syndrome Caused By a De Novo Mutation in the GATA2 Gene.

    Lymphology·2018
    Same author

    The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir Pharmacokinetics.

    Clinical pharmacology and therapeutics·2017
    Same author

    Pharmacokinetics of the transdermal fentanyl patch in a feline ovariohysterectomy model.

    Veterinary anaesthesia and analgesia·2017
    Same author

    Transforaminal endoscopic microdiscectomy. Indication and results.

    Der Orthopade·2017
    Same author

    [Osteotomy techniques close to the knee. Effect on wedge volume and bony contact surface].

    Der Orthopade·2014
    Same author

    [Arthroscopic nerve release and decompression of ganglion cysts around the shoulder joint].

    Operative Orthopadie und Traumatologie·2014

    Elderly patients require lower daily lithium doses to maintain therapeutic plasma levels, indicating age-related changes in lithium pharmacokinetics. This finding is crucial for optimizing lithium treatment in older adults.

    Area of Science:

    • Pharmacology
    • Geriatrics
    • Clinical Pharmacy

    Background:

    • Lithium is a key mood stabilizer for bipolar disorder.
    • Age-related physiological changes can impact drug pharmacokinetics and pharmacodynamics.
    • Optimal lithium dosing strategies in elderly populations require further investigation.

    Purpose of the Study:

    • To investigate the relationship between age and lithium dosage requirements in inpatients.
    • To determine if lithium dosage needs adjustment based on age groups.
    • To explore the pharmacokinetic implications of age on lithium therapy.

    Main Methods:

    • A study involving 78 inpatients across three age groups: ≤45, 46-64, and ≥65 years.
    • Patients were matched on relevant variables to control for confounding factors.

    Related Experiment Videos

  • Analysis of steady-state lithium plasma levels, daily lithium doses, and weight-related dose-to-plasma level ratios.

    • Main Results:

    • Mean daily lithium doses were significantly lower in elderly patients (≥65 years).
    • No significant differences were observed in mean steady-state lithium plasma levels across age groups.
    • A 36% decline in the weight-related lithium dose-to-plasma level ratio was observed with increasing age, with a notable decrease around 50 years.

    Conclusions:

    • Elderly patients require lower daily lithium doses to achieve therapeutic plasma concentrations.
    • Age-related alterations in lithium's volume of distribution and/or elimination half-life, potentially due to decreased glomerular filtration rate, likely explain the reduced dosage needs.
    • These findings necessitate careful lithium dose individualization in geriatric patients to ensure efficacy and minimize toxicity.